MDASI
Showing 51 - 75 of 327
Pancreatic Cancer, Ovarian Cancer, Adenocarcinoma Trial in Houston (TROP2-CAR-NK, Cyclophosphamide, Fludarabine)
Not yet recruiting
- Pancreatic Cancer
- +2 more
- TROP2-CAR-NK
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 27, 2023
Head Neck Cancer, Survivorship, Caregiver Burden Trial in Charleston (Survivorship Needs Assessment Planning (SNAP) tool)
Not yet recruiting
- Head and Neck Cancer
- +3 more
- Survivorship Needs Assessment Planning (SNAP) tool
-
Charleston, South CarolinaMedical University of South Carolina
Mar 31, 2023
Head Neck Cancer, Quality of Life, Pain Trial in Kaohsiung (Hydrogen Inhalation, Ordinary Air Inhalation)
Recruiting
- Head and Neck Cancer
- +4 more
- Hydrogen Inhalation
- Ordinary Air Inhalation
-
Kaohsiung, TaiwanKaohsiung Medical University Chung-Ho Memorial Hospital
Feb 10, 2023
Acute Myeloid Leukemia Trial in Duarte (procedure, drug, biological, other, radiation)
Recruiting
- Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 8, 2022
Anxiety Trial run by the National Cancer Institute (NCI) (Pico G2 4K Headset with Applied VR software)
Recruiting
- Anxiety
- Pico G2 4K Headset with Applied VR software
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 30, 2023
Brain Metastases, Nonsmall Cell Lung Cancer Stage III Trial in Winston-Salem (MRI of the Brain, Blood draws, Quality of Life
Not yet recruiting
- Brain Metastases
- Nonsmall Cell Lung Cancer Stage III
- MRI of the Brain
- +2 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Cente
Jan 19, 2023
Oropharyngeal Squamous Cell Carcinoma Trial in Philadelphia (adjuvant radiotherapy)
Recruiting
- Oropharyngeal Squamous Cell Carcinoma
- adjuvant radiotherapy
-
Philadelphia, Pennsylvania
- +2 more
Feb 2, 2023
Liver Metastases Trial in Houston (Leucovorin, 5-FLUOROURACIL, Oxaliplatin)
Recruiting
- Liver Metastases
- Leucovorin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Apr 26, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (Behavioral Intervention, Interview,
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Behavioral Intervention
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 14, 2022
Chronic Lymphocytic Leukemia Trial in Houston (Questionnaire Administration, Ruxolitinib Phosphate)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Questionnaire Administration
- Ruxolitinib Phosphate
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Metastatic Malignant Tumor in the Brain Trial (procedure, other, radiation)
Not yet recruiting
- Metastatic Malignant Neoplasm in the Brain
- Brain Surgery
- +3 more
- (no location specified)
Jun 24, 2022
Hematologic Malignancy Trial in Copenhagen (HM-PRO)
Active, not recruiting
- Hematologic Malignancy
- HM-PRO
-
Copenhagen, DenmarkDept. of Hematology
Jun 14, 2022
Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3 Trial in United States (other, radiation, drug)
Active, not recruiting
- Astrocytoma, IDH-Mutant, Grade 2
- Astrocytoma, IDH-Mutant, Grade 3
- Questionnaire Administration
- +3 more
-
Phoenix, Arizona
- +24 more
Dec 7, 2022
Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic Trial in Scottsdale (Botensilimab, Balstilimab, Chloroquine
Not yet recruiting
- Pancreatic Cancer Metastatic
- Pancreatic Adenocarcinoma Metastatic
- Botensilimab
- +3 more
-
Scottsdale, ArizonaClinical Trials Nurse Navigator
Oct 3, 2023
Chemo-induced Nausea and Vomiting Trial in Chicago (Granisetron Transdermal Patch, Intravenous Dexamethasone, Ondansetron)
Recruiting
- Chemotherapy-induced Nausea and Vomiting
- Granisetron Transdermal Patch
- +2 more
-
Chicago, IllinoisUniversity of Illinois Cancer Center
Jun 7, 2022
HPV-positive Oropharyngeal Squamous Cell Carcinoma Trial in New York (procedure, radiation, drug)
Recruiting
- HPV-positive Oropharyngeal Squamous Cell Carcinoma
- Robotic surgery
- +2 more
-
New York, New YorkMount Sinai Health System
Oct 26, 2022
Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Houston (drug, behavioral, radiation)
Not yet recruiting
- Squamous Cell Carcinoma
- Oral Cavity Squamous Cell Carcinoma
- Tiragolumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 27, 2023
Well-being of Caregivers (Caregiver Strain Index) Trial in Durham (home care)
Recruiting
- Well-being of Caregivers (Caregiver Strain Index)
- home care
-
Durham, North CarolinaDuke University Medical Center
Jan 25, 2023
AAV2hAQP1 for Radiation Induced Xerostomia
Enrolling by invitation
- Radiation-induced Xerostomia
-
Stanford, California
- +3 more
Dec 22, 2022
Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (Ixazomib Citrate, Lenalidomide,
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- Plasma Cell Myeloma
- Ixazomib Citrate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Mar 8, 2022
Ovary Cancer, Stage II-IV, Quality of Life, Depressive Symptoms Trial (POSTCare Survivorship transition process)
Not yet recruiting
- Ovary Cancer, Stage II-IV
- +2 more
- POSTCare Survivorship transition process
- (no location specified)
Feb 22, 2023
Brain Metastases, Radiosurgery Trial (Hippocampal-sparing, Stereotactic radiosurgery)
Not yet recruiting
- Brain Metastases
- Radiosurgery
- Hippocampal-sparing
- Stereotactic radiosurgery
- (no location specified)
Feb 10, 2022
Breast Cancer Trial in Lagos (mHealth psychoeducational intervention)
Not yet recruiting
- Breast Cancer
- mHealth psychoeducational intervention
-
Lagos, Nigeria
- +1 more
Aug 4, 2022
Brain Tumor, Brain Cancer Trial in Houston (Standard Fitbit Program, Virtual Exercise Program)
Not yet recruiting
- Brain Tumor
- Brain Cancer
- Standard Fitbit Program
- Virtual Exercise Program
-
Houston, TexasM D Anderson Cancer Center
Sep 26, 2022
Gastric Carcinoma Trial in China (Yiqi Wenyang Jiedu prescription, Simulation agent of Yiqi Wenyang Jiedu prescription)
Recruiting
- Gastric Carcinoma
- Yiqi Wenyang Jiedu prescription
- Simulation agent of Yiqi Wenyang Jiedu prescription
-
Beijing, Beijing, China
- +5 more
Oct 31, 2022